49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IPR-16009451	2016-11-01	2016-10-16	The Efficacy and Safety of Low Dose IL-2 Conbined RapamycinTherapy in Chinese Over-treated Patients ...	The Efficacy and Safety of Low Dose IL-2 Conbined RapamycinTherapy in Chinese Over-treated Patients ...	Systemic Lupus Erythematosus	IL-2group:IL-2;IL-2+ Rapamycingroup :IL-2and Rapamycin;non IL-2or IL-6 antagonist group :Glucocortic ...	the Second Hospital of Shanxi Medical University	NULL	Pending	18	80	Both	IL-2 group:20;IL-2 + Rapamycin group :20;non IL-2 or IL-6 antagonist group :20;		China
2	NCT00779194 (ClinicalTrials.gov)	October 2008	23/10/2008	Prospective Study of Rapamycin for the Treatment of SLE	Prospective Study of Rapamycin for the Treatment of SLE	Systemic Lupus Erythematosus (SLE)	Drug: Rapamycin	State University of New York - Upstate Medical University	Pfizer;Pfizer	Completed	18 Years	N/A	Both	40	Phase 2	United States

First Previous1Next Last